Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues.
Lisco A, Vanpouille C, Tchesnokov EP, Grivel JC, Biancotto A, Brichacek B, Elliott J, Fromentin E, Shattock R, Anton P, Gorelick R, Balzarini J, McGuigan C, Derudas M, Götte M, Schinazi RF, Margolis L. Lisco A, et al. Cell Host Microbe. 2008 Sep 11;4(3):260-270. doi: 10.1016/j.chom.2008.07.008. Cell Host Microbe. 2008. PMID: 18779052 Free PMC article.
Acyclovir: a new use for an old drug.
Vanpouille C, Lisco A, Margolis L. Vanpouille C, et al. Among authors: lisco a. Curr Opin Infect Dis. 2009 Dec;22(6):583-7. doi: 10.1097/QCO.0b013e32833229b8. Curr Opin Infect Dis. 2009. PMID: 19726982 Review.
A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.
Vanpouille C, Lisco A, Derudas M, Saba E, Grivel JC, Brichacek B, Scrimieri F, Schinazi R, Schols D, McGuigan C, Balzarini J, Margolis L. Vanpouille C, et al. Among authors: lisco a. J Infect Dis. 2010 Feb 15;201(4):635-43. doi: 10.1086/650343. J Infect Dis. 2010. PMID: 20085496 Free PMC article.
HSV-2 suppression and the incidence of HIV.
Lisco A, Vanpouille C. Lisco A, et al. N Engl J Med. 2008 Jul 31;359(5):535; author reply 535. doi: 10.1056/NEJMc081075. N Engl J Med. 2008. PMID: 18669436 No abstract available.
Coinfecting viruses as determinants of HIV disease.
Lisco A, Vanpouille C, Margolis L. Lisco A, et al. Curr HIV/AIDS Rep. 2009 Feb;6(1):5-12. doi: 10.1007/s11904-009-0002-3. Curr HIV/AIDS Rep. 2009. PMID: 19149991 Free PMC article. Review.
Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin.
Vanpouille C, Lisco A, Introini A, Grivel JC, Munawwar A, Merbah M, Schinazi RF, Derudas M, McGuigan C, Balzarini J, Margolis L. Vanpouille C, et al. Among authors: lisco a. Antimicrob Agents Chemother. 2012 May;56(5):2604-11. doi: 10.1128/AAC.05986-11. Epub 2012 Feb 6. Antimicrob Agents Chemother. 2012. PMID: 22314523 Free PMC article.
98 results